- Home
- Equipment
- australasia
- cancer drug
Show results for
Refine by
Cancer Drug Equipment Supplied In Australasia
3 equipment items found
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
DEP® cabazitaxel is an enhanced version of leading prostate cancer drug cabazitaxel (Jevtana®). Cabazitaxel (Jevtana®) had global sales of €536M in 2020 despite having multiple US FDA “Black Box” warnings. ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
DEP® irinotecan is an improved version of irinotecan (Camptosar®), predominantly used for colorectal cancer. DEP® irinotecan is a novel, patented nanoparticle formulation of SN-38, the active metabolite of irinotecan, delivered using Starpharma’s proprietary DEP® technology. Irinotecan (Camptosar®) is a major cancer drug ...
Manufactured by:ICU Medical, Inc. based inSan Clemente, CALIFORNIA (USA)
Maintain a needlefree closed system to help minimize exposure to hazardous drugs and comply with USP. Prohibits the escape of hazardous drug or vapor concentrations, Blocks the transfer of environmental contaminants into the system, Eliminates needlestick injuries while minimizing , hazardous drug exposure. With the ChemoLock needlefree CSTD, it ...